Gaudium IVF and Women Health Limited

listedRefreshing

NSE · Source: NSE

DRHP18 Aug 2026completed
RHP18 Aug 2026completed
Price band18 Aug 2026completed
Opened20 Feb 2026completed
Closed24 Feb 2026completed
Allotteddate not on filereached, date not recorded
Listed27 Feb 2026completed

Price band

₹75–₹79

Issue size

—

Fresh issue

₹90 Cr

Offer for sale

—

Context

What the company does

Gaudium IVF and Women Health Limited specializes in IVF treatments, operating over 30 locations across India. The company aims to assist couples facing infertility through personalized care and advanced reproductive technologies, including the Gaudium Advanced Analysis and Treatment (GAAT) module designed to enhance success rates.

Industry opportunity

The IVF industry is rapidly growing, with the Indian market projected to expand from USD 1.32 billion in 2024 to USD 4.54 billion by 2034. This growth is driven by increasing infertility rates, advancements in technology, and changing societal norms, presenting significant opportunities for Gaudium IVF.